Refractory overactive bladder patients who chose sacral neuromodulation therapy after failed OnabotulinumtoxinA treatment: A systematic review and meta-analysis.
<h4>Objective</h4>To systematically review outcomes in patients with refractory overactive bladder (OAB) patients who underwent sacral neuromodulation therapy (SNM) therapy after unsuccessful onabotulinumtoxinA (BTX) therapy, and to compare outcomes with those who SNM as initial therapy....
Main Authors: | Guang Yang, Yong Xu, Genyi Qu, Yulong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0230355 |
Similar Items
-
OnabotulinumtoxinA for the treatment of overactive bladder
by: Cox L, et al.
Published: (2014-07-01) -
Intradetrusor OnabotulinumtoxinA outcomes for overactive bladder in older adults
by: Rachel Stading, et al.
Published: (2024-12-01) -
New developments in the management of overactive bladder: focus on mirabegron and onabotulinumtoxinA
by: Andersson KE
Published: (2013-04-01) -
Does the setting for intradetrusor onabotulinumtoxinA injection for management of overactive bladder matter?
by: James H. Ross, et al.
Published: (2024-04-01) -
A Feasibility Study to Evaluate Changes in Urinary Metabolites after OnabotulinumtoxinA Injection for Refractory Overactive Bladder
by: Laura M. Tellechea, et al.
Published: (2022-09-01)